Invesco Ltd. Zentalis Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 51,462 shares of ZNTL stock, worth $150,269. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,462

Previous 53,809 4.36%

Holding current value

$150,269

Previous $220,000 14.55%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$2.9 - $4.57 $6,806 - $10,725	-2,347 Reduced 4.36%	51,462 $188,000
Q2 2024 Aug 13, 2024	SELL	$4.09 - $16.13 $2,278 - $8,984	-557 Reduced 1.02%	53,809 $220,000
Q1 2024 May 14, 2024	BUY	$10.83 - $16.49 $318,575 - $485,069	29,416 Added 117.9%	54,366 $856,000
Q4 2023 Feb 12, 2024	SELL	$9.84 - $20.13 $1.1 Million - $2.25 Million	-111,611 Reduced 81.73%	24,950 $377,000
Q3 2023 Nov 13, 2023	BUY	$19.63 - $28.29 $123,296 - $177,689	6,281 Added 4.82%	136,561 $2.74 Million
Q2 2023 Aug 11, 2023	BUY	$17.41 - $30.05 $1.82 Million - $3.14 Million	104,647 Added 408.25%	130,280 $3.68 Million
Q1 2023 May 12, 2023	BUY	$16.14 - $24.94 $9,280 - $14,340	575 Added 2.29%	25,633 $440,000
Q4 2022 Feb 13, 2023	SELL	$18.07 - $25.6 $35,381 - $50,124	-1,958 Reduced 7.25%	25,058 $504,000
Q3 2022 Nov 14, 2022	BUY	$20.23 - $31.73 $68,599 - $107,596	3,391 Added 14.35%	27,016 $586,000
Q2 2022 Aug 15, 2022	SELL	$17.91 - $52.25 $1.32 Million - $3.86 Million	-73,830 Reduced 75.76%	23,625 $664,000
Q1 2022 May 16, 2022	SELL	$41.58 - $80.89 $5.06 Million - $9.84 Million	-121,660 Reduced 55.52%	97,455 $4.5 Million
Q4 2021 Feb 14, 2022	BUY	$66.92 - $84.79 $5.91 Million - $7.49 Million	88,303 Added 67.5%	219,115 $18.4 Million
Q3 2021 Nov 15, 2021	SELL	$46.83 - $73.5 $676,084 - $1.06 Million	-14,437 Reduced 9.94%	130,812 $8.72 Million
Q2 2021 Aug 17, 2021	SELL	$37.41 - $62.25 $3.28 Million - $5.46 Million	-87,758 Reduced 37.66%	145,249 $7.73 Million
Q1 2021 May 17, 2021	SELL	$35.69 - $52.72 $1.54 Million - $2.27 Million	-43,062 Reduced 15.6%	233,007 $10.1 Million
Q4 2020 Feb 16, 2021	BUY	$31.71 - $57.97 $93,861 - $171,591	2,960 Added 1.08%	276,069 $14.3 Million
Q3 2020 Nov 16, 2020	SELL	$27.03 - $47.97 $115,796 - $205,503	-4,284 Reduced 1.54%	273,109 $8.93 Million
Q2 2020 Aug 14, 2020	BUY	$23.2 - $54.8 $6.44 Million - $15.2 Million	277,393 New	277,393 $13.3 Million

Others Institutions Holding ZNTL

# of Institutions

142

Shares Held

67.9M

Call Options Held

48.5K

Put Options Held

89.6K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $166M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account